NRC
NRC Health
Price Chart
Latest Quote
$19.63
| Previous Close | $19.49 |
| Open | $19.40 |
| Day High | $19.83 |
| Day Low | $19.23 |
| Volume | 45,434 |
Stock Information
| Quarterly Dividend / Yield | $0.60 / 3.08% |
| Shares Outstanding | 22.54M |
| Quarterly Dividend Yield | 3.08% |
| Quarterly Dividend | $0.60 |
| Total Debt | $78.03M |
| Cash Equivalents | $2.55M |
| Revenue | $138.64M |
| Net Income | $8.59M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $451.64M |
| P/E Ratio | 51.38 |
| EPS (TTM) | $0.39 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $514.73M |
| Sales | $138.64M |
| Income | $8.59M |
| Book/sh | $0.60 |
| Cash/sh | $0.11 |
| Employees | 357 |
Financial Ratios
| Quick Ratio | 0.36 |
| Current Ratio | 0.52 |
| Debt/Eq | 578.23 |
| EPS Growth TTM | -44.30% |
Returns & Margins
| ROA | 12.21% |
| ROE | 41.86% |
| Gross Margin | 61.80% |
| Operating Margin | 16.00% |
| Profit Margin | 6.52% |
Ownership
| Insider Ownership | 48.87% |
| Institutional Ownership | 49.63% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 18.73 |
| PEG | 1.32 |
| P/S | 3.26 |
| P/B | 33.46 |
Analyst Data
| Recommendation | buy |
| Target Price | $23.00 |
Technical Indicators
| SMA20 | $19.28 |
| SMA50 | $18.52 |
| SMA200 | $16.44 |
| RSI | 52.22 |
| ATR | 1.1904 |
| Shares Float | 12.23M |
| Short Float | 16.52% |
| Short Ratio | 3.97 |
| Volatility | 0.40 |
| Rel Volume | 0.54 |
Performance History
| Week | +9.45% |
| Month | +5.25% |
| Quarter | +15.50% |
| 6 Months | +5.69% |
| YTD | +12.17% |
| Year | +25.26% |
| 3 Years | -50.93% |
| 5 Years | -49.44% |
| 10 Years | +80.62% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $20.04 | 92,707 |
| 2026-06-22 | $19.49 | 153,500 |
| 2026-06-18 | $18.54 | 357,200 |
| 2026-06-17 | $17.75 | 92,900 |
| 2026-06-16 | $18.47 | 84,400 |
| 2026-06-15 | $18.31 | 109,700 |
| 2026-06-12 | $18.79 | 87,300 |
| 2026-06-11 | $18.79 | 261,800 |
| 2026-06-10 | $21.28 | 759,800 |
| 2026-06-09 | $19.75 | 164,600 |
| 2026-06-08 | $19.33 | 118,700 |
| 2026-06-05 | $19.14 | 152,500 |
| 2026-06-04 | $19.75 | 134,800 |
| 2026-06-03 | $19.04 | 167,500 |
| 2026-06-02 | $19.59 | 110,300 |
| 2026-06-01 | $20.25 | 190,200 |
| 2026-05-29 | $19.53 | 87,400 |
| 2026-05-28 | $19.66 | 140,300 |
| 2026-05-27 | $19.13 | 88,700 |
| 2026-05-26 | $19.04 | 90,700 |
About NRC Health
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments. It also provides patient experience solutions, a cross-continuum multi-mode digital platform that collects and measures data to improve patient experience, engagement, and loyalty; employee experience solutions, which combines health care with technology comprising engagement, pulse, lifecycle, culture of safety, and magnet RN satisfaction; and consumer experience solution that offers online reputation solutions, community insights, and cross-journey listening through nGage. In addition, the company offers Huey, an AI engine built for Human Understanding that serves as a healthcare experience management companion; and governance solutions provided through national conferences, publications, advisory services, and an online portal for not-for-profit health system boards of directors, executives, and physician leadership. Further, it provides patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company was formerly known as National Research Corporation and changed its name to NRC Health April 2026. The company was founded in 1981 and is headquartered in Lincoln, Nebraska.
đ° Latest News
There May Be Reason For Hope In NRC Health's (NASDAQ:NRC) Disappointing Earnings
Simply Wall St. âĸ 2026-05-13T10:20:58ZNRC Health's Q1 Earnings Fall Y/Y Due to Elevated Operating Costs
Zacks âĸ 2026-05-01T14:00:00ZNRC Health (NRC) Q1 2026 Earnings Call Highlights: Record TRCV and Landmark Deals Propel Growth
GuruFocus.com âĸ 2026-04-29T07:10:13ZNational Research Q1 Earnings Call Highlights
MarketBeat âĸ 2026-04-28T23:39:07ZNRC Health Surges 62% in a Year: Should You Buy the Stock?
Zacks âĸ 2026-04-15T17:15:00ZTSX Penny Stocks With Market Caps Over CA$100M To Consider
Simply Wall St. âĸ 2026-04-07T13:05:22ZWhat Makes National Research Corporation (NRC) a Good Investment Choice?
Insider Monkey âĸ 2026-03-13T12:05:17ZNRC's Q4 Earnings Down Y/Y on High Client Attrition, Stock Falls 27%
Zacks âĸ 2026-02-09T17:50:00ZA Look At The Fair Value Of National Research Corporation (NASDAQ:NRC)
Simply Wall St. âĸ 2026-02-04T10:17:28ZNational Research Q4 Earnings Call Highlights
MarketBeat âĸ 2026-02-04T01:08:56ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $52,371,000 | $56,933,000 | $56,015,000 | $57,049,000 |
| Cost Of Revenue | $52,371,000 | $56,933,000 | $56,015,000 | $57,049,000 |
| Total Revenue | $137,390,000 | $143,060,000 | $148,580,000 | $151,568,000 |
| Operating Revenue | $137,390,000 | $143,060,000 | $148,580,000 | $151,568,000 |
| Expenses | ||||
| Interest Expense | $4,761,000 | $2,595,000 | $862,000 | $1,209,000 |
| Total Expenses | $114,800,000 | $107,866,000 | $108,535,000 | $105,025,000 |
| Other Income Expense | $-95,000 | $-34,000 | $-41,000 | $-2,687,000 |
| Other Non Operating Income Expenses | $-95,000 | $-34,000 | $-41,000 | $-118,000 |
| Net Non Operating Interest Income Expense | $-4,650,000 | $-2,470,000 | $-42,000 | $-1,041,000 |
| Interest Expense Non Operating | $4,761,000 | $2,595,000 | $862,000 | $1,209,000 |
| Operating Expense | $62,429,000 | $50,933,000 | $52,520,000 | $47,976,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $11,600,000 | $24,783,000 | $30,971,000 | $31,800,000 |
| Net Interest Income | $-4,650,000 | $-2,470,000 | $-42,000 | $-1,041,000 |
| Interest Income | $111,000 | $125,000 | $820,000 | $168,000 |
| Normalized Income | $11,600,000 | $24,783,000 | $30,971,000 | $33,701,060 |
| Net Income From Continuing And Discontinued Operation | $11,600,000 | $24,783,000 | $30,971,000 | $31,800,000 |
| Total Operating Income As Reported | $22,590,000 | $35,194,000 | $40,045,000 | $46,543,000 |
| Net Income Common Stockholders | $11,292,000 | $24,781,000 | $30,963,000 | $31,784,000 |
| Net Income | $11,600,000 | $24,783,000 | $30,971,000 | $31,800,000 |
| Net Income Including Noncontrolling Interests | $11,600,000 | $24,783,000 | $30,971,000 | $31,800,000 |
| Net Income Continuous Operations | $11,600,000 | $24,783,000 | $30,971,000 | $31,800,000 |
| Pretax Income | $17,845,000 | $32,690,000 | $39,962,000 | $42,815,000 |
| Interest Income Non Operating | $111,000 | $125,000 | $820,000 | $168,000 |
| Operating Income | $22,590,000 | $35,194,000 | $40,045,000 | $46,543,000 |
| Depreciation Amortization Depletion Income Statement | $7,624,000 | $6,022,000 | $5,899,000 | $5,277,000 |
| Depreciation And Amortization In Income Statement | $7,624,000 | $6,022,000 | $5,899,000 | $5,277,000 |
| Gross Profit | $85,019,000 | $86,127,000 | $92,565,000 | $94,519,000 |
| Special Income Charges | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $0.50 | $1.04 | $1.25 | $1.27 |
| Basic EPS | $0.50 | $1.05 | $1.26 | $1.28 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $-667,940 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $30,230,000 | $41,307,000 | $46,723,000 | $51,870,000 |
| Reconciled Depreciation | $7,624,000 | $6,022,000 | $5,899,000 | $5,277,000 |
| EBITDA (Bullshit earnings) | $30,230,000 | $41,307,000 | $46,723,000 | $49,301,000 |
| EBIT | $22,606,000 | $35,285,000 | $40,824,000 | $44,024,000 |
| Diluted Average Shares | $22,396,000 | $23,743,000 | $24,673,000 | $25,052,000 |
| Basic Average Shares | $22,383,000 | $23,703,000 | $24,540,000 | $24,922,000 |
| Diluted NI Availto Com Stockholders | $11,292,000 | $24,781,000 | $30,963,000 | $31,784,000 |
| Otherunder Preferred Stock Dividend | $308,000 | $2,000 | $8,000 | $16,000 |
| Tax Provision | $6,245,000 | $7,907,000 | $8,991,000 | $11,015,000 |
| Selling General And Administration | $54,805,000 | $44,911,000 | $46,621,000 | $42,699,000 |
| Total Unusual Items | - | - | - | $-2,569,000 |
| Total Unusual Items Excluding Goodwill | - | - | - | $-2,569,000 |
| Gain On Sale Of Security | - | - | - | $-2,569,000 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-54,389,000 | $-37,484,000 | $-14,130,000 | $8,808,000 |
| Total Assets | $134,878,000 | $132,539,000 | $122,437,000 | $130,461,000 |
| Total Non Current Assets | $114,669,000 | $112,939,000 | $98,077,000 | $86,745,000 |
| Other Non Current Assets | $3,318,000 | $4,340,000 | $3,274,000 | $3,261,000 |
| Non Current Deferred Assets | $2,498,000 | $1,562,000 | $1,453,000 | $2,455,000 |
| Goodwill And Other Intangible Assets | $68,379,000 | $68,768,000 | $63,085,000 | $63,225,000 |
| Other Intangible Assets | $2,227,000 | $2,616,000 | $1,471,000 | $1,611,000 |
| Current Assets | $20,209,000 | $19,600,000 | $24,360,000 | $43,716,000 |
| Other Current Assets | $520,000 | $692,000 | $940,000 | $1,110,000 |
| Prepaid Assets | $3,914,000 | $3,480,000 | $4,228,000 | $2,386,000 |
| Receivables | $11,636,000 | $11,195,000 | $12,539,000 | $15,194,000 |
| Taxes Receivable | $528,000 | $141,000 | $161,000 | $733,000 |
| Accounts Receivable | $11,108,000 | $11,054,000 | $12,378,000 | $14,461,000 |
| Allowance For Doubtful Accounts Receivable | $-80,000 | $-40,000 | $-75,000 | $-65,000 |
| Gross Accounts Receivable | $11,188,000 | $11,094,000 | $12,453,000 | $14,526,000 |
| Cash Cash Equivalents And Short Term Investments | $4,139,000 | $4,233,000 | $6,653,000 | $25,026,000 |
| Cash And Cash Equivalents | $4,139,000 | $4,233,000 | $6,653,000 | $25,026,000 |
| Non Current Deferred Taxes Assets | - | - | $0 | $14,000 |
| Debt | ||||
| Net Debt | $74,896,000 | $58,451,000 | $30,031,000 | - |
| Total Debt | $79,035,000 | $62,684,000 | $36,684,000 | $22,181,000 |
| Long Term Debt And Capital Lease Obligation | $75,021,000 | $57,895,000 | $29,470,000 | $17,690,000 |
| Long Term Debt | $75,021,000 | $57,895,000 | $29,470,000 | $17,690,000 |
| Current Debt And Capital Lease Obligation | $4,014,000 | $4,789,000 | $7,214,000 | $4,491,000 |
| Current Debt | $4,014,000 | $4,789,000 | $7,214,000 | $4,491,000 |
| Other Current Borrowings | $4,014,000 | $4,789,000 | $7,214,000 | $4,491,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $120,888,000 | $101,255,000 | $73,482,000 | $58,428,000 |
| Total Non Current Liabilities Net Minority Interest | $84,268,000 | $65,397,000 | $37,279,000 | $25,011,000 |
| Other Non Current Liabilities | $3,263,000 | $3,971,000 | $3,670,000 | $2,047,000 |
| Non Current Deferred Liabilities | $5,984,000 | $3,531,000 | $4,139,000 | $5,274,000 |
| Non Current Deferred Taxes Liabilities | $5,984,000 | $3,531,000 | $4,139,000 | $5,274,000 |
| Current Liabilities | $36,620,000 | $35,858,000 | $36,203,000 | $33,417,000 |
| Other Current Liabilities | $946,000 | $1,101,000 | $880,000 | $1,085,000 |
| Current Deferred Liabilities | $16,201,000 | $15,786,000 | $14,834,000 | $15,198,000 |
| Payables And Accrued Expenses | $15,459,000 | $14,182,000 | $13,275,000 | $12,643,000 |
| Payables | $5,344,000 | $4,317,000 | $4,429,000 | $4,109,000 |
| Dividends Payable | $3,625,000 | $2,770,000 | $2,906,000 | $2,956,000 |
| Total Tax Payable | $550,000 | $353,000 | $222,000 | $0 |
| Income Tax Payable | $550,000 | $353,000 | $222,000 | $0 |
| Accounts Payable | $1,169,000 | $1,194,000 | $1,301,000 | $1,153,000 |
| Equity | ||||
| Common Stock Equity | $13,990,000 | $31,284,000 | $48,955,000 | $72,033,000 |
| Total Equity Gross Minority Interest | $13,990,000 | $31,284,000 | $48,955,000 | $72,033,000 |
| Stockholders Equity | $13,990,000 | $31,284,000 | $48,955,000 | $72,033,000 |
| Retained Earnings | $-17,298,000 | $-17,064,000 | $-30,530,000 | $-25,184,000 |
| Gains Losses Not Affecting Retained Earnings | - | $0 | $0 | $0 |
| Other Equity Adjustments | - | - | - | - |
| Other | ||||
| Treasury Shares Number | $9,329,252 | $7,989,028 | $6,783,032 | $6,294,008 |
| Ordinary Shares Number | $22,637,252 | $23,083,116 | $24,219,887 | $24,628,173 |
| Share Issued | $31,966,504 | $31,072,144 | $31,002,919 | $30,922,181 |
| Tangible Book Value | $-54,389,000 | $-37,484,000 | $-14,130,000 | $8,808,000 |
| Invested Capital | $93,025,000 | $93,968,000 | $85,639,000 | $94,214,000 |
| Working Capital | $-16,411,000 | $-16,258,000 | $-11,843,000 | $10,299,000 |
| Total Capitalization | $89,011,000 | $89,179,000 | $78,425,000 | $89,723,000 |
| Treasury Stock | $152,624,000 | $131,932,000 | $98,759,000 | $78,267,000 |
| Additional Paid In Capital | $183,880,000 | $180,249,000 | $178,213,000 | $175,453,000 |
| Capital Stock | $32,000 | $31,000 | $31,000 | $31,000 |
| Common Stock | $32,000 | $31,000 | $31,000 | $31,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Current Deferred Revenue | $16,201,000 | $15,786,000 | $14,834,000 | $15,198,000 |
| Current Accrued Expenses | $10,115,000 | $9,865,000 | $8,846,000 | $8,534,000 |
| Goodwill | $66,152,000 | $66,152,000 | $61,614,000 | $61,614,000 |
| Net PPE | $40,474,000 | $38,269,000 | $30,265,000 | $17,804,000 |
| Accumulated Depreciation | $-40,732,000 | $-35,384,000 | $-35,669,000 | $-33,508,000 |
| Gross PPE | $81,206,000 | $73,653,000 | $65,934,000 | $51,312,000 |
| Leases | $488,000 | $488,000 | $488,000 | $502,000 |
| Machinery Furniture Equipment | $46,244,000 | $39,352,000 | $40,527,000 | $37,268,000 |
| Buildings And Improvements | $34,049,000 | $33,388,000 | $22,434,000 | $12,561,000 |
| Land And Improvements | $425,000 | $425,000 | $425,000 | $425,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Properties | - | $1,627,000 | $2,060,000 | $556,000 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $15,744,000 | $19,177,000 | $22,334,000 | $26,430,000 |
| Operating Activities | ||||
| Operating Cash Flow | $26,450,000 | $34,625,000 | $38,113,000 | $36,265,000 |
| Cash Flow From Continuing Operating Activities | $26,450,000 | $34,625,000 | $38,113,000 | $36,265,000 |
| Operating Gains Losses | $128,000 | $17,000 | - | $11,000 |
| Investing Activities | ||||
| Capital Expenditure | $-10,706,000 | $-15,448,000 | $-15,779,000 | $-9,835,000 |
| Investing Cash Flow | $-10,706,000 | $-20,281,000 | $-15,778,000 | $-9,835,000 |
| Cash Flow From Continuing Investing Activities | $-10,706,000 | $-20,281,000 | $-15,778,000 | $-9,835,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-20,180,000 | $-30,945,000 | $-19,099,000 | $-27,616,000 |
| Financing Cash Flow | $-15,838,000 | $-16,764,000 | $-40,707,000 | $-55,583,000 |
| Cash Flow From Continuing Financing Activities | $-15,838,000 | $-16,764,000 | $-40,707,000 | $-55,583,000 |
| Net Other Financing Charges | $-1,057,000 | $-359,000 | $-8,000 | $-2,232,000 |
| Cash Dividends Paid | $-10,978,000 | $-11,453,000 | $-36,366,000 | $-20,961,000 |
| Common Stock Dividend Paid | $-10,978,000 | $-11,453,000 | $-36,366,000 | $-20,961,000 |
| Net Common Stock Issuance | $-20,180,000 | $-30,945,000 | $-19,099,000 | $-27,616,000 |
| Other | ||||
| Repayment Of Debt | $-68,436,000 | $-55,507,000 | $-19,818,000 | $-4,774,000 |
| Issuance Of Debt | $84,681,000 | $81,500,000 | $34,000,000 | $0 |
| Interest Paid Supplemental Data | $4,485,000 | $2,440,000 | $803,000 | $1,227,000 |
| End Cash Position | $4,139,000 | $4,233,000 | $6,653,000 | $25,026,000 |
| Beginning Cash Position | $4,233,000 | $6,653,000 | $25,026,000 | $54,361,000 |
| Effect Of Exchange Rate Changes | $0 | $0 | $-1,000 | $-182,000 |
| Changes In Cash | $-94,000 | $-2,420,000 | $-18,372,000 | $-29,153,000 |
| Proceeds From Stock Option Exercised | $132,000 | $0 | $584,000 | $0 |
| Common Stock Payments | $-20,180,000 | $-30,945,000 | $-19,099,000 | $-27,616,000 |
| Net Issuance Payments Of Debt | $16,245,000 | $25,993,000 | $14,182,000 | $-4,774,000 |
| Net Long Term Debt Issuance | $16,245,000 | $25,993,000 | $14,182,000 | $-4,774,000 |
| Long Term Debt Payments | $-68,436,000 | $-55,507,000 | $-19,818,000 | $-4,774,000 |
| Long Term Debt Issuance | $84,681,000 | $81,500,000 | $34,000,000 | $0 |
| Net Business Purchase And Sale | $0 | $-4,833,000 | $0 | $0 |
| Purchase Of Business | $0 | $-4,833,000 | $0 | $0 |
| Net PPE Purchase And Sale | $-10,706,000 | $-15,448,000 | $-15,778,000 | $-9,835,000 |
| Sale Of PPE | $0 | $0 | $1,000 | $0 |
| Purchase Of PPE | $-10,706,000 | $-15,448,000 | $-15,779,000 | $-9,835,000 |
| Change In Working Capital | $916,000 | $3,814,000 | $986,000 | $-3,351,000 |
| Change In Other Working Capital | $-895,000 | $242,000 | $1,292,000 | $-716,000 |
| Change In Payables And Accrued Expense | $1,840,000 | $66,000 | $-623,000 | $-3,536,000 |
| Change In Accrued Expense | $1,670,000 | $174,000 | $-807,000 | $-2,947,000 |
| Change In Payable | $170,000 | $-108,000 | $184,000 | $-589,000 |
| Change In Account Payable | $170,000 | $-108,000 | $184,000 | $-589,000 |
| Change In Prepaid Assets | $24,000 | $1,749,000 | $-1,767,000 | $1,634,000 |
| Change In Receivables | $-53,000 | $1,757,000 | $2,084,000 | $-733,000 |
| Changes In Account Receivables | $-53,000 | $1,757,000 | $2,084,000 | $-733,000 |
| Other Non Cash Items | $243,000 | $111,000 | $39,000 | $2,569,000 |
| Stock Based Compensation | $3,312,000 | $284,000 | $935,000 | $1,200,000 |
| Deferred Tax | $2,627,000 | $-406,000 | $-717,000 | $-1,241,000 |
| Deferred Income Tax | $2,627,000 | $-406,000 | $-717,000 | $-1,241,000 |
| Depreciation Amortization Depletion | $7,624,000 | $6,022,000 | $5,899,000 | $5,277,000 |
| Depreciation And Amortization | $7,624,000 | $6,022,000 | $5,899,000 | $5,277,000 |
| Gain Loss On Sale Of PPE | $61,000 | $17,000 | $0 | $11,000 |
| Net Income From Continuing Operations | $11,600,000 | $24,783,000 | $30,971,000 | $31,800,000 |
| Income Tax Paid Supplemental Data | - | $8,225,000 | $8,932,000 | $12,233,000 |
| Depreciation | - | $6,022,000 | $5,899,000 | $5,277,000 |
| Provisionand Write Offof Assets | - | - | - | $488,000 |